BF.B
48
-5
HSIC
40
-4
PLD
61
-3
EMN
66
-6
EXPE
69
2
NWL
19
-9
HRL
26
2
JCI
32
-3
ALLE
30
-7
GS
70
4
AMAT
58
3
PH
62
-2
CMG
61
-2
RIG
26
-2
ADSK
72
2
GD
59
-5
CRM
57
2
CI
50
-3
MSFT
67
2
PNR
50
-12
BF.B
48
-5
HSIC
40
-4
PLD
61
-3
EMN
66
-6
EXPE
69
2
NWL
19
-9
HRL
26
2
JCI
32
-3
ALLE
30
-7
GS
70
4
AMAT
58
3
PH
62
-2
CMG
61
-2
RIG
26
-2
ADSK
72
2
GD
59
-5
CRM
57
2
CI
50
-3
MSFT
67
2
PNR
50
-12
Financhill
Back

Greek Organisation of Football Prognostics SA Vs. Keros Therapeutics Industry Stock Comparison

Sell
32

GOFPY
Greek Organisation of Football Prognostics SA

Last Price:
7.83
Seasonality Move:
-1.96%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.52
Seasonality Move:
4.22%
Sell
32
Greek Organisation of Football Prognostics SA (GOFPY) is a Sell

Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?

  • The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $7.79. The Score for GOFPY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GOFPY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOFPY Stock Price Chart

What is Greek Organisation of Football Prognostics SA's stock price today?

  • The Greek Organisation of Football Prognostics SA share price today is $7.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOFPY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

GOFPY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 43.07 Sell
Chaikin Money Flow: 10111 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.8 - 8.14) Sell
Bollinger Bands (100): (8.15 - 9.07) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

GOFPY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.89 Sell
20-day SMA: 7.93 Sell
50-day SMA: 8.24 Sell
200-day SMA: 8.43 Sell
8-day EMA: 7.83 Sell
20-day EMA: 7.95 Sell
50-day EMA: 8.19 Sell
200-day EMA: 8.39 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Greek Organisation of Football Prognostics SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):